Abstract
Inflammatory breast cancer (IBC) is a rare, poorly understood and aggressive tumor. We extended prior findings linking high body mass index (BMI) to substantial increased IBC risk by examining BMI associations before and after adjustment for well-characterized comorbidities using medical record data for diabetes, insulin resistance, and disturbances of cholesterol metabolism in a general community healthcare setting. We identified 247 incident IBC cases diagnosed at Kaiser Permanente Northern California between 2005 and 2017 and 2470 controls matched 10:1 on birth year and geographic area and with ≥ 13 months of continuous enrollment prior to diagnosis/index date. We assessed exposures from 6 years up to one year prior to the diagnosis/index date, using logistic regression to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Before adjustment for comorbidities, ORs (95% CIs) for BMI of 25-< 30, 30-< 35, and ≥ 35 compared to < 25 kg/m2 were 1.5 (0.9-2.3), 2.0 (1.2-3.1), and 2.5 (1.4-4.4), respectively. After adjustment for pre-diabetes/diabetes, HDL-C and triglyceride levels, and dyslipidemia, corresponding ORs were 1.3 (0.8-2.1), 1.6 (0.9-2.9), and 1.9 (1.0-3.5). The OR for HDL-C levels < 50 mg/dL compared to ≥ 6...Continue Reading
References
Dec 16, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S ChangS D Hursting
Jul 7, 2005·Journal of the National Cancer Institute·Kenneth W HancePaul H Levine
Jun 1, 2006·Breast Disease·William F AndersonPaul H Levine
Nov 7, 2008·International Journal of Cancer. Journal International Du Cancer·Reiko SuzukiAlicja Wolk
Jun 22, 2010·Cancer·Peter B VermeulenLuc Y Dirix
Jan 28, 2012·Nature·Harold Varmus, Ed Harlow
Jun 9, 2012·Preventing Chronic Disease·Gregory A NicholsUNKNOWN SUPREME-DM Study Group
Jul 7, 2012·Annals of Epidemiology·Corinna KoebnickLawrence H Kushi
Nov 6, 2012·European Journal of Nutrition·Peter BoylePhilippe Autier
Feb 15, 2013·Cancer Causes & Control : CCC·Philippe AutierPeter Boyle
Apr 11, 2013·Menopause : the Journal of the North American Menopause Society·Katherine EspositoDario Giugliano
Apr 23, 2013·Diabetes Care·Kai McKeever BullardCarl J Caspersen
Sep 17, 2013·The British Journal of Surgery·K M J De BruijnC H J van Eijck
Sep 21, 2013·Journal of the National Cancer Institute·Laleh Amiri-KordestaniJo Anne Zujewski
Sep 21, 2013·Journal of the National Cancer Institute·Catherine SchairerDiana L Miglioretti
Jun 10, 2014·PloS One·Adrian V HernandezHerbert Lazaro
Sep 12, 2014·Diabetologia·Yi HuangYuli Huang
Jun 11, 2015·Drugs·Ulrike HostalekSteven Hildemann
Jul 16, 2015·The British Journal of Nutrition·Mathilde TouvierPaule Latino-Martel
Nov 1, 2015·Cancers·David P RoseLinda Vona-Davis
Nov 12, 2015·PloS One·Haibo NiRong Gao
Jan 23, 2016·Cancer Causes & Control : CCC·Rachel L AtkinsonAbenaa M Brewster
Jun 25, 2016·International Journal of Molecular Sciences·Shawna B Matthews, Henry J Thompson
Jul 19, 2016·Current Opinion in Pharmacology·Ryan KolbWeizhou Zhang
Jan 4, 2017·Endocrine·Lorenzo ScappaticcioKatherine Esposito
Jan 15, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Catherine SchairerEric A Engels
Jun 14, 2017·Mediators of Inflammation·Riley J MorrowMatthias Ernst
Nov 16, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Gagan Priya, Sanjay Kalra
Feb 17, 2018·Breast Cancer Research and Treatment·Catherine SchairerRuth M Pfeiffer
Mar 3, 2019·Breast Cancer Research : BCR·Laura Garcia-Estevez, Gema Moreno-Bueno